Global Health Narrows Half-Year Loss as Net Tangible Liabilities Deepen

The latest update is out from Global Health Limited ( (AU:GLH) ).

Global Health Limited reported half-year revenue of A$3.59 million for the period ended 31 December 2025, a 1.19% decline from the prior corresponding period, and recorded a net loss after tax of A$629,201, slightly improved from the A$686,754 loss a year earlier. The company did not declare or pay any dividends, and its net tangible liabilities per share widened to 7.43 cents from 6.06 cents, underscoring ongoing balance-sheet pressure despite modest progress in narrowing losses; the accounts were reviewed without qualification, suggesting no major audit concerns but highlighting continued challenges in achieving profitability and strengthening tangible asset backing.

The most recent analyst rating on (AU:GLH) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Global Health Limited stock, see the AU:GLH Stock Forecast page.

More about Global Health Limited

Global Health Limited operates in the healthcare technology sector, providing digital health and software solutions to healthcare providers and related institutions. Its offerings focus on supporting clinical, administrative and patient management functions, with operations spanning Australia and overseas subsidiaries that report under both Australian and international accounting standards.

Average Trading Volume: 47,363

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$4.29M

For detailed information about GLH stock, go to TipRanks’ Stock Analysis page.